• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Rely on clinical skills to diagnose ferret adrenal disease

June 1, 2004
Johnny D. Hoskins, DVM, PhD, DACVIM

Medical treatment of adrenal disease is usually reserved for ferrets that are poor surgical candidates.

Signalment:

Mustelidae, Ferret, 7 years old, F/S, 1.5 lbs.

Clinical history:

The ferret presented for losing hair on the tail.

Physical examination:

The findings include rectal temperature 101°F, no heart murmur heard, pink mucous membranes, and nonsluggish capillary refill time at <1 second. The ferret is bright/alert/responsive, normal lymph nodes, normal abdomen, hair loss of tail, gingivitis and dental disease. There has been no therapy.

Editor's Note: In our ongoing telemedicine series, Dr. Johnny Hoskins presents medical case studies. The format is heavily focused on radiology and ultrasonography and details complicated, yet fairly common cases most veterinarians will be exposed to in practice.

Laboratory results:

A partial complete blood count and serum chemistry profile was performed and is outlined in Table 1. Urinalysis was not done. The fecal examination is negative for parasites.

Radiographic review:

Survey abdominal radiographs are done.

Advertisement

My comments:

The abdominal radiographs show enlarged spleen, soft tissue mass associated with left kidney and another soft tissue mass next to the right kidney.

Ultrasound examination:

Thorough abdominal ultrasonography is performed with the ferret positioned in dorsal recumbency.

My comments:

The liver shows an inhomogeneous texture in its parenchyma. No masses noted within the liver parenchyma. The gall bladder is mildly distended, and its walls are not thickened or hyperechoic. The gall bladder does contain a lot of sludge material. The spleen is prominent (sedated used for the study) and shows an inhomogeneous texture in its parenchyma - no masses noted. The left and right kidneys are similar in size, shape and echotexture. Each kidney shows an inhomogeneous texture in the renal cortex. A large cortical cyst is present in the caudal pole of the left kidney. No masses or calculi were noted in either kidney. The urinary bladder is distended with urine and contains some urine sediment material - no masses or calculi noted.

Image2

The stomach, small intestine and pancreas are normal. The pancreas shows a decreased mixed echogenicity in its parenchyma.

An irregular-shaped echogenic area with a single anechoic lesion is seen caudal to the liver and cranial to the right kidney. An echogenic irregular-shaped area with an anechoic lesion in its parenchyma is seen in the mid-abdomen cranial to the right kidney.

Another lesion of similar shape and echotexture is seen in the right cranial abdomen, caudoventral to the liver and dorsal to the spleen.

Image3

Case management:

In this case, adrenal tumors are the primary clinical differential diagnosis. At this point, an exploratory laparotomy would be warranted to possibly remove the neoplastic process, inspect the abdominal cavity for potential metastatic disease and collect appropriate biopsies for histopathologic examination. Therapy thereafter would depend on the findings from the exploratory laparotomy and histopathologic examination.

Image4

Review adrenal tumors:

Adrenal gland tumors are a common problem for ferrets 3 years and older, although this condition can occur at any age. The most common signs of an adrenal tumor are: hair loss or thinning on the body of the ferret (in advanced cases, hair may only remain on the head and feet and some have only their whiskers remaining); loss of muscle mass and a pot-bellied appearance; thin skin or almost translucent; itchiness; excessive water consumption; aggressive or mating behavior (mating behavior with inanimate objects, i.e., their blanket, stuffed toys, etc.); and an enlarged vulva.

Image5

In males, urination difficulties may be present due to enlarged prostatic tissue and this can become life-threatening if not treated.

Adrenal disease in ferrets is usually diagnosed by clinical signs. There are no definitive tests that can be performed that will reveal adrenal disease. Standard blood work will be normal assuming the ferret is healthy in every respect except for the adrenal problem.

There is currently only one hormonal panel that will confirm adrenal disease in the ferret, which is run by the University of Tennessee, School of Veterinary Medicine - this test is often referred to as "The Tennessee Panel." Radiography and ultrasonography may be useful at times in the diagnosis of adrenal disease. Diseased adrenal glands can frequently be normal in size and shape and, therefore, will appear normal in radiography and ultrasonography.

Image6

Clinical signs

If ferrets are exhibiting the clinical signs of adrenal disease, then money is better spent on going right into surgery rather than on expensive tests. Surgery is the most effective treatment for adrenal disease and involves the removal of the affected adrenal gland.

In most cases, and for reasons unknown, the left gland is most often affected. This is fortunate since removal of the left adrenal gland is relatively easy in comparison to the right adrenal gland. The right gland is often attached to the vena cava and removal can be difficult.

Image7

Medical treatment of adrenal disease is usually reserved for ferrets that are poor surgical candidates. They may be older ferrets or ferrets with other medical problems that would make surgery high risk. Some people will opt for medical treatment because of the cost of surgery. Drug treatment must be continued for the rest of the ferret's life and in the long run can cost more than surgical correction.

The drugs used most frequently and successfully for the treatment of adrenal disease are Lupron and Melatonin. Neither will cure the disease but only provide a relief of the signs. Gonadotropin release hormone (GnRH) is released by the hypothalamus in a pulsatile manner to stimulate the pituitary gland to release FSH and LH into the bloodstream. It is necessary for normal pituitary function that the hypothalamus release GnRH in brief discontinuous pulses rather than sustained continuous secretion. The pituitary gland can and will rapidly lose its responsiveness to GnRH if exposed for extended intervals of time - become desensitized.

Lupron (leuprolide acetate) is a synthetic version of GnRH. It is more stable than the natural hormone and, therefore, is degraded much more slowly within the body. This is the key to how Lupron works. Once in the bloodstream, Lupron acts at the pituitary gland just as natural GnRH does.

However, since Lupron is administered at a relatively high dosage and isn't degraded easily, the sustained presence of the drug actually causes the pituitary gland to desensitize and, thus, cease production of LH and FSH.

While some ferrets with adrenal disease do well on Lupron, some ferrets may be unresponsive. This scenario could arise if the adrenal gland has become diseased in a way such that the zona reticularis will produce androgens independent of any regulation by FSH and LH.

If this should occur, the adrenal gland would probably continue to hypersecrete androgens even after Lupron therapy has reduced levels of FSH and LH. Since some ferrets do respond well to Lupron, it is often worth trying if the ferret owner is uncomfortable with the idea of surgery as a first remedy.

Also, Lupron therapy is a life-long protocol: the ferret will require regular doses of Lupron to keep the malfunctioning adrenal gland under control. In the long run, this can be more expensive than surgery, which is presumably a one-time procedure.

Monthly injection of Lupron is given at a dosage of 100 mcg/kg in the muscle of the back leg and then increased to 200 mcg/kg if it is adrenal carcinoma or if the ferret does not respond after two injections. Also, one can use Lupron depot once every four months at 2-3 mg/kg every four to six months intramuscularly. The dosage of 2 mg/kg every four months is five times higher than the 100 mcg (0.1 mg)/kg once a month when compared on a monthly basis. Either way, Lupron is an expensive human product.

There are two other GnRH analogs: Zoladex and Synarel. Zoladex (goserelin acetate) is also a long-acting GnRH analog. It comes in a monthly version and a three-month version. The main problem with Zoladex is it comes packaged already in a syringe, so it would be very hard to divide into sterile dosages small enough for ferrets.

This is also an expensive human product. Synarel (nafarelin acetate) is a nasal solution that would have to be given nasally twice a day. It would be extremely hard to divide this into small enough dosages for ferrets and then give it twice a day nasally.

Melatonin is another product that should stop the stimulation to the adrenal glands. Melatonin is a natural hormone that is secreted by the pineal gland. Melatonin is involved in activating (in the spring) and terminating (in the fall) the ferret hypothalamic-pituitary-gonadal axis in response to the seasonal changes in the photoperiod (amount of daylight).

Melatonin inhibits GnRH release, decreases LH and FSH, and ultimately decreases the sex hormone concentrations. Most of the work with melatonin in ferrets was done with intact jills to bring them into heat or to take them out of heat.

The questions about melatonin are the amount to give, time to administer the tablet, and the long-term effects on the adrenal hormones.

A suggestive dose is 1 mg/kg given around eight to nine hours after sunrise. Melatonin tablets are cheap and available without a prescription at various stores. Also, it is important to change the photoperiod to resemble winter (i.e. nine hours of light with 15 hours of darkness per day).

"In a recent study, 0.5 mg oral suspension of melatonin was administered once daily to 10 ferrets with confirmed adrenocortical disease. Ferrets were examined every four months for a year. In addition to clinical signs, ultrasonographic measurement of the adrenal glands, sex hormone concentrations and prolactin levels were measured. Nine of the 10 ferrets had moderate to dramatic improvement in clinical signs including hair growth, reduction of vulva swelling or reduction of prostatic size. There was no significant change in the size of the adrenal glands. Hormone concentrations varied greatly between each ferret, but all had one or more sex hormone with elevated plasma concentrations. Mean values of estradiol, 17-hydroxy-progesterone and DHEAS decreased after four months of treatment but the concentrations at eight and 12 months were higher than at initial levels. Androstenedione gradually increased in every ferret at each four-month interval. Prolactin concentrations steadily decreased throughout the 12-month period. Ferrets with adrenocortical disease may benefit from treatment with melatonin. This may involve melatonin's effect on gonadotropin or prolactin secretion from the pituitary gland.

Tumor growth is not affected by administration of melatonin. Even if tumor growth is not affected by the administration of melatonin, there is improvement in the coat and quality of life for ferrets with adrenocortical disease."

Lysodren mainly destroys the cortisol producing cells of the adrenal glands; however, in ferrets cortisol is not the problem. It is the sex steroids (estrogen, 17-hydroxy-progesterone and testosterone) and the androgens (DHEAS and androstenedione) that are being over-secreted. This is why Lysodren does not work well in ferrets. Furthermore, lowering cortisol levels can cause serious hypoglycemia problems if the ferret also has an insulinoma.

Information for this column contributed by Michael Janke at mjank@miamiferret.org. For more information go to www.miamiferret.org/

Related Content:

Endocrinology
Using in-clinic cortisol testing to detect endocrine diseases in dogs
Using in-clinic cortisol testing to detect endocrine diseases in dogs
The American Animal Hospital Association shares new endocrine guidelines
The American Animal Hospital Association shares new endocrine guidelines
Spectrum of care for diabetic patients
Spectrum of care for diabetic patients

Advertisement

Latest News

Morris Animal Foundation announces fellowships

Zoetis announces Apoquel grant program

American Veterinary Medical Foundation welcomes new executive director

Details of new pet performance supplement line revealed

View More Latest News
Advertisement